<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81629</article-id><article-id pub-id-type="doi">10.7554/eLife.81629</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Characterisation of the immune repertoire of a humanised transgenic mouse through immunophenotyping and high-throughput sequencing</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-285191"><name><surname>Richardson</surname><given-names>Eve</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5499-6283</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-301815"><name><surname>Binter</surname><given-names>Špela</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-287661"><name><surname>Kosmac</surname><given-names>Miha</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5372-7233</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-250256"><name><surname>Ghraichy</surname><given-names>Marie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250257"><name><surname>von Niederhäusern</surname><given-names>Valentin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9150-2361</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252622"><name><surname>Kovaltsuk</surname><given-names>Aleksandr</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3806-8302</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-194521"><name><surname>Galson</surname><given-names>Jacob D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4916-800X</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-59096"><name><surname>Trück</surname><given-names>Johannes</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0418-7381</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49432"><name><surname>Kelly</surname><given-names>Dominic F</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-30961"><name><surname>Deane</surname><given-names>Charlotte M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1388-2252</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301816"><name><surname>Kellam</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" corresp="yes" id="author-301817"><name><surname>Watson</surname><given-names>Simon J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf6"/></contrib><aff id="aff1"><institution content-type="dept">Department of Statistics</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution>Kymab</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Division of Immunology</institution>, <institution>University of Zurich</institution>, <addr-line><named-content content-type="city">Zurich</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff4"><institution>Alchemab Therapeutics Ltd</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Department of Paediatrics</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-110082"><name><surname>Sen</surname><given-names>Ranjan</given-names></name><role>Reviewing editor</role><aff><institution>National Institute on Aging</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>deane@stats.ox.ac.uk</email> (CD);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>Simon.Watson@rqbiotechnology.com</email> (SW);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e81629</elocation-id><history><date date-type="received"><day>05</day><month>07</month><year>2022</year></date><date date-type="accepted"><day>26</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Richardson et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Richardson et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81629-v1.pdf"/><abstract><p>Immunoglobulin loci-transgenic animals are widely used in antibody discovery and increasingly in vaccine response modelling. In this study, we phenotypically characterised B-cell populations from the Intelliselect® Transgenic mouse (Kymouse) demonstrating full B-cell development competence. Comparison of the naïve B-cell receptor (BCR) repertoires of Kymice BCRs, naïve human, and murine BCR repertoires revealed key differences in germline gene usage and junctional diversification. These differences result in Kymice having CDRH3 length and diversity intermediate between mice and humans. To compare the structural space explored by CDRH3s in each species’ repertoire, we used computational structure prediction to show that Kymouse naïve BCR repertoires are more human-like than mouse-like in their predicted distribution of CDRH3 shape. Our combined sequence and structural analysis indicates that the naïve Kymouse BCR repertoire is diverse with key similarities to human repertoires, while immunophenotyping confirms that selected naïve B-cells are able to go through complete development.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Bill &amp; Melinda Gates Foundation</institution></institution-wrap></funding-source><award-id>OPP1159947</award-id><principal-award-recipient><name><surname>Kellam</surname><given-names>Paul</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/R015708/1</award-id><principal-award-recipient><name><surname>Richardson</surname><given-names>Eve</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Eve Richardson, Eve Richardson receives funding from Kymab Ltd..</p></fn><fn fn-type="conflict" id="conf3"><p>Špela Binter, Špela Binter is an employee of Kymab Ltd..</p></fn><fn fn-type="conflict" id="conf4"><p>Miha Kosmac, Miha Kosmac was an employee of Kymab within the last three years..</p></fn><fn fn-type="conflict" id="conf5"><p>Paul Kellam, Paul Kellam is an employee of Kymab Ltd..</p></fn><fn fn-type="conflict" id="conf6"><p>Simon J Watson, Simon Watson is an employee of Kymab Ltd..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was carried out under Project Licenses 70/8718 issued by the UK Government Home Office under Animal (Scientific Procedures) Act (A(SP)A), 1986, incorporating Directive 2010/63/EU of the European Parliament, and with the approval of the Sanger Institute Animal Welfare and Ethical Review Body. The Institute complied with the Code of Practice issued by the UK Government which aids compliance with the A(SP)A. The Institute has a PHS assurance F16-00128 (WTSI).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The processed paired sequencing data is available at doing 10.5281/zenodo.7474232  and the processed bulk VH sequence data has been deposited in the Observed Antibody Space (http://opig.stats.ox.ac.uk/webapps/oas/oas). Immunophenotyping data is available in the FlowRepository (https://flowrepository.org/) under IDs FR-FCM-Z5LB (bone marrow samples) and FR-FCM-Z5LC (splenocyte and lymph node samples).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Richardson E</collab><collab>Binter S</collab><collab>Watson SJ</collab></person-group><year iso-8601-date="2022">2022</year><source>IGM sequences from naïve Kymouse 1</source><ext-link ext-link-type="uri" xlink:href="http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-1_Richardson_2022_1_Heavy_IGHM.csv.gz">http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-1_Richardson_2022_1_Heavy_IGHM.csv.gz</ext-link><comment>Observed Antibody Space</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Binter S</collab><collab>Watson SJ</collab></person-group><year iso-8601-date="2022">2022</year><source>Characterisation of the immune repertoire of a humanised transgenic mouse through immunophenotyping and high-throughput sequencing (bone marrow)</source><ext-link ext-link-type="uri" xlink:href="http://flowrepository.org/id/FR-FCM-Z5LB">http://flowrepository.org/id/FR-FCM-Z5LB</ext-link><comment>FlowRepository,  FR-FCM-Z5LB</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Binter S</collab><collab>Watson SJ</collab></person-group><year iso-8601-date="2022">2022</year><source>Characterisation of the immune repertoire of a humanised transgenic mouse through immunophenotyping and high-throughput sequencing (spleen)</source><ext-link ext-link-type="uri" xlink:href="http://flowrepository.org/id/FR-FCM-Z5LC">http://flowrepository.org/id/FR-FCM-Z5LC</ext-link><comment>FlowRepository, FR-FCM-Z5LC</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Richardson E</collab><collab>Binter S</collab><collab>Watson SJ</collab></person-group><year iso-8601-date="2022">2022</year><source>IGM sequences from naïve Kymouse 2</source><ext-link ext-link-type="uri" xlink:href="http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-2_Richardson_2022_1_Heavy_IGHM.csv.gz">http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-2_Richardson_2022_1_Heavy_IGHM.csv.gz</ext-link><comment>Observed Antibody Space</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Richardson E</collab><collab>Binter S</collab><collab>Watson SJ</collab></person-group><year iso-8601-date="2022">2022</year><source>IGM sequences from naïve Kymouse 3</source><ext-link ext-link-type="uri" xlink:href="http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-3_Richardson_2022_1_Heavy_IGHM.csv.gz">http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-3_Richardson_2022_1_Heavy_IGHM.csv.gz</ext-link><comment>Observed Antibody Space</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Richardson E</collab><collab>Binter S</collab><collab>Watson SJ</collab></person-group><year iso-8601-date="2022">2022</year><source>IGM sequences from naïve Kymouse 4</source><ext-link ext-link-type="uri" xlink:href="http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-4_Richardson_2022_1_Heavy_IGHM.csv.gz">http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-4_Richardson_2022_1_Heavy_IGHM.csv.gz</ext-link><comment>Observed Antibody Space</comment></element-citation><element-citation id="dataset7" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Richardson E</collab><collab>Binter S</collab><collab>Watson SJ</collab></person-group><year iso-8601-date="2022">2022</year><source>IGM sequences from naïve Kymouse 5</source><ext-link ext-link-type="uri" xlink:href="http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-5_Richardson_2022_1_Heavy_IGHM.csv.gz">http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-5_Richardson_2022_1_Heavy_IGHM.csv.gz</ext-link><comment>Observed Antibody Space</comment></element-citation><element-citation id="dataset8" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Richardson E</collab><collab>Binter S</collab><collab>Watson SJ</collab></person-group><year iso-8601-date="2022">2022</year><source>IGM sequences from naïve Kymouse 6</source><ext-link ext-link-type="uri" xlink:href="http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-6_Richardson_2022_1_Heavy_IGHM.csv.gz">http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-6_Richardson_2022_1_Heavy_IGHM.csv.gz</ext-link><comment>Observed Antibody Space</comment></element-citation><element-citation id="dataset9" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Richardson E</collab><collab>Binter S</collab><collab>Watson SJ</collab></person-group><year iso-8601-date="2022">2022</year><source>IGM sequences from naïve Kymouse 7</source><ext-link ext-link-type="uri" xlink:href="http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-7_Richardson_2022_1_Heavy_IGHM.csv.gz">http://opig.stats.ox.ac.uk/webapps/oas/dataunit?unit=Richardson/csv/Mouse-7_Richardson_2022_1_Heavy_IGHM.csv.gz</ext-link><comment>Observed Antibody Space</comment></element-citation><element-citation id="dataset10" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Richardson E</collab><collab>Binter S</collab><collab>Watson SJ</collab></person-group><year iso-8601-date="2022">2022</year><source>Paired VH:VL IGM sequences from 22 naïve Kymice</source><ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/7474233#.Y6S1NuzP3DE">https://zenodo.org/record/7474233#.Y6S1NuzP3DE</ext-link><comment>Zenodo, 10.5281/zenodo.7474232</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset11" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ghraichy M</collab><collab>Trück J</collab></person-group><year iso-8601-date="2021">2021</year><source>Pre-processed IgH repertoire sequencing data from BioProject PRJNA748239</source><ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/5155565#.YuFlHy2ZPdc">https://zenodo.org/record/5155565#.YuFlHy2ZPdc</ext-link><comment>Zenodo, doi:10.5281/zenodo.5155565</comment></element-citation><element-citation id="dataset12" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Greiff V</collab><collab>Menzel U</collab><collab>Miho E</collab><collab>Weber C</collab><collab>Riedel R</collab><collab>Cook S</collab><collab>Valai A</collab><collab>Lopes T</collab><collab>Radbruch A</collab><collab>Winkler TH</collab><collab>Reddy ST</collab></person-group><year iso-8601-date="2017">2017</year><source>Antibody repertoire RNA-seq throughout key stages of mouse B-cell development (pre-B-cells, naive B cells, plasma cells)</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5349/">https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-5349/</ext-link><comment>ArrayExpress, E-MTAB-5349</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-81629-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>